194 related articles for article (PubMed ID: 1679434)
1. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
Tamai I; Safa AR
J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434
[TBL] [Abstract][Full Text] [Related]
2. Competitive interaction of cyclosporins with the Vinca alkaloid-binding site of P-glycoprotein in multidrug-resistant cells.
Tamai I; Safa AR
J Biol Chem; 1990 Sep; 265(27):16509-13. PubMed ID: 1975813
[TBL] [Abstract][Full Text] [Related]
3. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.
Safa AR; Agresti M; Bryk D; Tamai I
Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the azidopine and vinblastine binding site of P-glycoprotein.
Bruggemann EP; Currier SJ; Gottesman MM; Pastan I
J Biol Chem; 1992 Oct; 267(29):21020-6. PubMed ID: 1356986
[TBL] [Abstract][Full Text] [Related]
5. BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
Liu Z; Lheureux F; Pouliot JF; Heckel A; Bamberger U; Georges E
Mol Pharmacol; 1996 Sep; 50(3):482-92. PubMed ID: 8794885
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site.
Ferry DR; Russell MA; Cullen MH
Biochem Biophys Res Commun; 1992 Oct; 188(1):440-5. PubMed ID: 1358068
[TBL] [Abstract][Full Text] [Related]
7. Modulators of the multidrug-transporter, P-glycoprotein, exist in the human plasma.
Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Akiyama S
Biochem Biophys Res Commun; 1990 Jan; 166(1):74-80. PubMed ID: 1967939
[TBL] [Abstract][Full Text] [Related]
8. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus.
Yang CP; DePinho SG; Greenberger LM; Arceci RJ; Horwitz SB
J Biol Chem; 1989 Jan; 264(2):782-8. PubMed ID: 2562956
[TBL] [Abstract][Full Text] [Related]
9. Functional studies of P-glycoprotein in inside-out plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR 3. Properties and kinetics of the interaction of vinblastine with P-glycoprotein and evidence for its active mediated transport.
Schlemmer SR; Sirotnak FM
J Biol Chem; 1994 Dec; 269(49):31059-66. PubMed ID: 7983045
[TBL] [Abstract][Full Text] [Related]
10. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers.
Safa AR; Glover CJ; Sewell JL; Meyers MB; Biedler JL; Felsted RL
J Biol Chem; 1987 Jun; 262(16):7884-8. PubMed ID: 3034908
[TBL] [Abstract][Full Text] [Related]
11. Detection of oligomeric and monomeric forms of P-glycoprotein in multidrug resistant cells.
Poruchynsky MS; Ling V
Biochemistry; 1994 Apr; 33(14):4163-74. PubMed ID: 7908829
[TBL] [Abstract][Full Text] [Related]
12. Photoaffinity probes for the alpha 1-adrenergic receptor and the calcium channel bind to a common domain in P-glycoprotein.
Greenberger LM; Yang CP; Gindin E; Horwitz SB
J Biol Chem; 1990 Mar; 265(8):4394-401. PubMed ID: 1968459
[TBL] [Abstract][Full Text] [Related]
13. Photoaffinity labeling of P-glycoprotein in multidrug resistant cells with photoactive analogs of colchicine.
Safa AR; Mehta ND; Agresti M
Biochem Biophys Res Commun; 1989 Aug; 162(3):1402-8. PubMed ID: 2569869
[TBL] [Abstract][Full Text] [Related]
14. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil.
Safa AR
Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7187-91. PubMed ID: 2902625
[TBL] [Abstract][Full Text] [Related]
15. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
Horio M; Lovelace E; Pastan I; Gottesman MM
Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
[TBL] [Abstract][Full Text] [Related]
16. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles.
Sinicrope FA; Dudeja PK; Bissonnette BM; Safa AR; Brasitus TA
J Biol Chem; 1992 Dec; 267(35):24995-5002. PubMed ID: 1360981
[TBL] [Abstract][Full Text] [Related]
17. Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein to a cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine.
Ferry D; Boer R; Callaghan R; Ulrich WR
Int J Clin Pharmacol Ther; 2000 Mar; 38(3):130-40. PubMed ID: 10739116
[TBL] [Abstract][Full Text] [Related]
18. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
[TBL] [Abstract][Full Text] [Related]
19. Megestrol acetate reverses multidrug resistance and interacts with P-glycoprotein.
Fleming GF; Amato JM; Agresti M; Safa AR
Cancer Chemother Pharmacol; 1992; 29(6):445-9. PubMed ID: 1348973
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
Pascaud C; Garrigos M; Orlowski S
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
